Physician profile
Dieter Pohl
NPI 1073535183
$7,583.20
in general payments reported to CMS, 2019-2025
17 companies · $1,720 in 2025
The $1,720 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,223 · 2020: $559 · 2021: $102 · 2022: $131 · 2023: $189 · 2024: $2,659 · 2025: $1,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,033 · Food and Beverage: $1,972 · Consulting Fee: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,032.91 |
| Food and Beverage | $1,972.41 |
| Consulting Fee | $562.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,609.13 | 2023-2025 | Endo Gia Ultra, Signia, Eea |
| W. L. Gore & Associates, INC. | $1,508.02 | 2024-2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Medical Device Business Services, INC. | $1,403.06 | 2019 | |
| Covidien Lp | $1,278.40 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $146.41 | 2024 | Voquezna |
| Intuitive Surgical, INC. | $106.11 | 2022 | |
| Merck Sharp & Dohme LLC | $100.83 | 2019 | |
| Novo Nordisk INC | $83.37 | 2022-2024 | Wegovy |
| Lilly USA, LLC | $60.82 | 2024-2025 | Omvoh |
| Boston Scientific Corporation | $56.44 | 2023 | Axios |
| Endo Pharmaceuticals INC. | $49.54 | 2021 | |
| Ethicon US, LLC | $44.95 | 2023-2025 | Stratafix, Echelon; Endopath |
| Takeda Pharmaceuticals U.S.A., INC. | $41.72 | 2021-2024 | Eohilia |
| Teleflex LLC | $33.63 | 2024 | Titan Sgs |
| Pacira Pharmaceuticals Incorporated | $27.79 | 2025 | Exparel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $17.73 | 2021 | |
| Hikma Pharmaceuticals USA | $15.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dieter Pohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.